Redefining adjuvant chemotherapy in patients with stage III colon cancer: X-ACT trial
H Glen, J Cassidy - Expert review of anticancer therapy, 2008 - Taylor & Francis
The current standard adjuvant chemotherapy for suitable patients with stage III colon cancer
is the combination of oxaliplatin and 5-fluorouracil plus folinic acid (5-FU/LV). However, until …
is the combination of oxaliplatin and 5-fluorouracil plus folinic acid (5-FU/LV). However, until …
Redefining adjuvant chemotherapy in patients with stage III colon cancer: X-ACT trial
H Glen, J Cassidy - Expert Review of Anticancer Therapy, 2008 - search.proquest.com
The current standard adjuvant chemotherapy for suitable patients with stage III colon cancer
is the combination of oxaliplatin and 5-fluorouracil plus folinic acid (5-FU/LV). However, until …
is the combination of oxaliplatin and 5-fluorouracil plus folinic acid (5-FU/LV). However, until …
Redefining adjuvant chemotherapy in patients with stage III colon cancer: X-ACT trial
H Glen, J Cassidy - Expert review of anticancer therapy, 2008 - pubmed.ncbi.nlm.nih.gov
The current standard adjuvant chemotherapy for suitable patients with stage III colon cancer
is the combination of oxaliplatin and 5-fluorouracil plus folinic acid (5-FU/LV). However, until …
is the combination of oxaliplatin and 5-fluorouracil plus folinic acid (5-FU/LV). However, until …
Redefining adjuvant chemotherapy in patients with stage III colon cancer: X-ACT trial.
H Glen, J Cassidy - Expert Review of Anticancer Therapy, 2008 - europepmc.org
The current standard adjuvant chemotherapy for suitable patients with stage III colon cancer
is the combination of oxaliplatin and 5-fluorouracil plus folinic acid (5-FU/LV). However, until …
is the combination of oxaliplatin and 5-fluorouracil plus folinic acid (5-FU/LV). However, until …
Redefining adjuvant chemotherapy in patients with stage III colon cancer: X-ACT trial
H Glen, J Cassidy - Expert Review of Anticancer Therapy, 2008 - eprints.gla.ac.uk
The current standard adjuvant chemotherapy for suitable patients with stage III colon cancer
is the combination of oxaliplatin and 5-fluorouracil plus folinic acid (5-FU/LV). However, until …
is the combination of oxaliplatin and 5-fluorouracil plus folinic acid (5-FU/LV). However, until …
Redefining adjuvant chemotherapy in patients with stage III colon cancer: X-ACT trial
H Glen, J Cassidy - Expert Review of Anticancer Therapy, 2008 - go.gale.com
Design The primary aim of the X-ACT study was to demonstrate at least equivalence in
terms of disease-free survival between capecitabine and bolus 5-FU/LV (Mayo Clinic …
terms of disease-free survival between capecitabine and bolus 5-FU/LV (Mayo Clinic …